Combination of Docetaxel Plus Savolitinib in Refractory Cancer Patients: A Report on Phase I Trial

Kim, ST; Lee, S; Park, M; Park, SH; Park, JO; Lim, HY; Park, YS; Kang, WK; Gangolli, EA; Shin, H; Kim, KM; Hollingsworth, SJ; Mortimer, PGS; Lee, J

Lee, J (reprint author), Sungkyunkwan Univ, Sch Med, Dept Med, Div Hematol Oncol,Samsung Med Ctr, 81 Irwon Ro, Seoul 06351, South Korea.

TRANSLATIONAL ONCOLOGY, 2019; 12 (4): 597

Abstract

MET amplification is a frequently observed genomic aberration in solid tumors. We conducted a phase I trial to evaluate dose-limiting toxicity (DLT) a......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索